Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (Aml) in First Remission Receiving Cc-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase Iii Quazar Aml-001 Trial
AuthID
P-00S-P2E
P-00S-P2E